/Companies

I Peace

Kyoto, JP · Founded 2015 · 1 known investors

Find your way into I Peace

Sign up to see every warm intro you have to I Peace

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the I Peace team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.

Founders & leadership

I Peace was founded in 2015 by Koji Tanabe and Tsuyoshi Tanabe.

KTKoji Tanabe
Koji TanabeFounder and CEOKoji Tanabe earned a Ph.D. from Shinya Yamanaka's laboratory where he contributed to early iPS cell research and co-authored publications on induced pluripotent stem cells, followed by postdoctoral work at Stanford. He founded I Peace in 2015 and has led the company across scientific research, business development, finance, intellectual property strategy, and manufacturing operations.
TT
Tsuyoshi TanabeFounder & CEO
JP
James PrentonExecutive
TS
Tsunesaburo SugayaExecutive

Board

HH
Hideya HayashiBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$47.1M disclosed across 5 rounds · 2016–2024

▶$9.7MraisedFeb 2025 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hideya HayashiDirector
  • James PrentonExecutive Officer
  • Koji TanabeExecutive Officer, Director
  • Tsunesaburo SugayaExecutive Officer, Director
Offering amount
$16M
Amount sold
$9.7M
First sale
Oct 2024
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.5MraisedNov 2024 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Koji TanabeExecutive Officer, Director
  • James PrentonExecutive Officer
  • Tsunesaburo SugayaExecutive Officer, Director
  • Hideya HayashiDirector
Offering amount
$16M
Amount sold
$8.5M
First sale
Oct 2024
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.8MraisedJun 2021 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Koji TanabeExecutive Officer, Director
  • James PrentonExecutive Officer
  • Tsunesaburo SugayaExecutive Officer, Director
  • Hideya HayashiDirector
Offering amount
$20.8M
Amount sold
$17.8M
First sale
Jun 2021
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hideya HayashiDirector
  • James PrentonExecutive Officer
  • Koji TanabeExecutive Officer, Director
  • Tsunesaburo SugayaExecutive Officer, Director
Offering amount
$6M
Amount sold
$6M
First sale
Dec 2016
Incorporated
Corporation, California, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJan 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James PrentonExecutive Officer
  • Tsunesaburo SugayaExecutive Officer, Director
Offering amount
$5.1M
Amount sold
$5.1M
First sale
Jan 2016
Incorporated
Corporation, California, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does I Peace do?
iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.
Who founded I Peace?
I Peace was founded by Koji Tanabe, Tsuyoshi Tanabe in 2015.
Who are I Peace's investors?
I Peace's investors include Hitachi Ventures.
How much funding has I Peace raised?
I Peace has disclosed $47.1M raised across 5 rounds.
Where is I Peace headquartered?
I Peace is headquartered in Kyoto, JP.